Nectar Lifesciences Limited

NSE:NECLIFE.NS

39.69 (INR) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 0198.06-203.507200.362-178.94175.8-142.712140.616-182.675177.75-164.354159.789-259.951255.01-2,073.672278.79-214.6212.56-1,882.445207.611-218.327212.89
Short Term Investments 04.948407.014134.389357.88420.733285.4241,676.497365.354.6328.7081,570.238519.9024.574,147.3441,794.882429.21.663,764.891,674.834436.6545.06
Cash and Short Term Investments 203.01203.008203.507334.751178.94596.533142.7121,817.113182.675182.35164.3541,730.027259.951259.582,073.6722,073.672214.6214.221,882.4451,882.445218.327217.95
Net Receivables 03,801.17103,004.39902,799.80503,260.39406,721.703,956.75606,196.7803,693.71806,069.1204,921.85107,164.57
Inventory 07,091.51506,485.59506,726.00106,851.6606,598.5506,246.91905,878.8809,043.7709,775.5109,432.73609,179.7
Other Current Assets 01,742.63502,256.67602,189.4940835.698045.890909.565053.050421.48092.730762.6990128.08
Total Current Assets 203.0112,838.329203.50712,081.421178.9412,311.833142.71212,764.865182.67513,548.49164.35412,843.267259.95112,388.292,073.67215,232.64214.616,151.581,882.44516,999.731218.32716,690.3
Non-Current Assets:
Property, Plant & Equipment, Net 06,560.61406,721.90406,904.28607,301.80707,651.7407,874.48808,321.5208,457.72308,606.5408,569.58408,851.88
Goodwill 0000000000000000000000
Intangible Assets 0523.9280507.6810493.2880461.4790430.210390.3750383.650344.4880391.910347.8960391.82
Goodwill and Intangible Assets 0523.9280507.6810493.2880461.4790430.210390.3750383.650344.4880391.910347.8960391.82
Long Term Investments 0112.3190-107.70202.3502.3510-1,610.8970-1,542.9430-2.220-1,767.58700.690-1,647.5390-2.36
Tax Assets 074.7780187.0470205.6880105.6590280150.52101,104.0802,017.07901,177.3401,722.92501,113.25
Other Non-Current Assets -203.011,800.595-203.5072,036.92-178.941,974.668-142.7122,247.506-182.6753,860.777-164.3543,965.975-259.9512,515.89-2,073.6721,063.337-214.65.02-1,882.4451,057.439-218.3274.99
Total Non-Current Assets -203.019,072.234-203.5079,345.85-178.949,580.28-142.71210,118.802-182.67510,359.83-164.35410,838.416-259.95112,322.92-2,073.67210,115.04-214.610,181.5-1,882.44510,050.305-218.32710,359.58
Total Assets 021,910.563021,427.271021,892.113022,883.667023,908.32023,681.683024,711.19025,347.68026,333.08027,050.036027,049.88
Liabilities & Equity:
Current Liabilities:
Account Payables 04,196.61203,404.73703,187.52303,627.3603,766.5203,500.50903,421.5303,754.30505,271.4505,441.55805,314.55
Short Term Debt 04,952.27604,979.78205,273.57305,319.34605,688.5104,856.74207,751.7206,613.44406,572.8206,572.84707,378.61
Tax Payables 00000000000000034.632036.050116.15090.07
Deferred Revenue 0123.330337.5650362.3140159.5970120.63301,127.1280700.6801,180.7810634.6501,066.828090.07
Other Current Liabilities 0455.9530123.245085.8630334.6070462.6670349.9670-0.010323.3430-0.010251.9050215.84
Total Current Liabilities 09,728.17108,845.32908,909.27309,440.91010,038.3309,834.346011,873.92011,871.873012,478.91013,333.138012,999.07
Non-Current Liabilities:
Long Term Debt 01,403.08701,832.92902,264.72102,576.94602,910.7503,101.90801,282.3701,220.35401,214.8201,226.73801,655.9
Deferred Revenue Non-Current 07.460007.710007.960008.210100.84708.460144.6208.71
Deferred Tax Liabilities Non-Current 0-7.46000-7.7100063.93000830.0501,039.75901,164.7801,136.62901,121.73
Other Non-Current Liabilities -10,692.4886.827074.711072.1730172.04308.31088.541096.3508.3330104.8708.7080212.86
Total Non-Current Liabilities -10,692.481,489.91401,907.6402,336.89402,748.98902,990.9503,190.44902,216.9802,369.29302,492.9302,516.69502,999.2
Total Liabilities -10,692.4811,218.085010,752.969011,246.167012,189.899013,029.28013,024.795014,090.9014,241.166014,971.84015,849.833015,998.27
Equity:
Preferred Stock 0000000000000000000000
Common Stock 0224.2610224.2610224.2610224.2610224.260224.2610224.260224.2610224.260224.2610224.26
Retained Earnings 07,039.210006,949.660007,191.480006,967.030007,707.980007,398.35
Accumulated Other Comprehensive Income/Loss 10,692.4810,468.21710,674.30210,450.04110,645.95184.0410,693.76810,469.50710,879.051141.0210,656.88810,432.62710,620.2973,512.2411,106.51410,882.25311,361.25-6,200.0811,200.20310,975.94211,051.611-5,749.76
Other Total Stockholders Equity 0-7,039.210003,287.9850003,322.28000-83.240009,629.080009,178.76
Total Shareholders Equity 10,692.4810,692.47810,674.30210,674.30210,645.9510,645.94610,693.76810,693.76810,879.05110,879.0410,656.88810,656.88810,620.29710,620.2911,106.51411,106.51411,361.2511,361.2411,200.20311,200.20311,051.61111,051.61
Total Equity 10,692.4810,692.47810,674.30210,674.30210,645.9510,645.94610,693.76810,693.76810,879.05110,879.0410,656.88810,656.88810,620.29710,620.2911,106.51411,106.51411,361.2511,361.2411,200.20311,200.20311,051.61111,051.61
Total Liabilities & Shareholders Equity 021,910.56310,674.30221,427.27110,645.9521,892.11310,693.76822,883.66710,879.05123,908.3210,656.88823,681.68310,620.29724,711.1911,106.51425,347.6811,361.2526,333.0811,200.20327,050.03611,051.61127,049.88